Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation

A hallmark of many chronic inflammatory and autoimmune diseases is that there is an impaired resolution of inflammation and return to the steady state. The infusion of high doses of pooled serum IgG preparations from thousands of donors [intravenous immunoglobulin (IVIG) therapy] has been shown to i...

Full description

Saved in:
Bibliographic Details
Published in:International immunology 2017-12, Vol.29 (11), p.499-509
Main Authors: Brückner, Christin, Lehmann, Christian, Dudziak, Diana, Nimmerjahn, Falk
Format: Article
Language:English
Subjects:
Animals
Autoimmune Diseases - immunology
Autoimmune Diseases - therapy
Cell Adhesion Molecules - immunology
Humans
Immunoglobulin G - immunology
Immunoglobulins, Intravenous - immunology
Immunoglobulins, Intravenous - therapeutic use
Inflammation - immunology
Inflammation - therapy
Lectins, C-Type - immunology
Receptors, Cell Surface - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A hallmark of many chronic inflammatory and autoimmune diseases is that there is an impaired resolution of inflammation and return to the steady state. The infusion of high doses of pooled serum IgG preparations from thousands of donors [intravenous immunoglobulin (IVIG) therapy] has been shown to induce resolution of inflammation in a variety of chronic inflammatory and autoimmune diseases, suggesting that IgG molecules can instruct the immune system to stop inflammatory processes and initiate the return to the steady state. The aim of this review is to discuss how insights into the mechanism of IVIG activity may help to understand the molecular and cellular pathways underlying resolution of inflammation. We will put a special emphasis on pathways dependent on the IgG FC domain and IgG sialylation, as several recent studies have provided new insights into how this glycosylation-dependent pathway modulates innate and adaptive immune responses through different sets of C-type or I-type lectins.
ISSN:0953-8178
1460-2377
DOI:10.1093/intimm/dxx053